ANNOUNCING: BRANDON SUH, OUR NEW CEO

We’re pleased to announce that we have appointed our new Chief Executive Officer (CEO), Brandon Suh.

With Brandon as our new CEO, we would like to open a new phase of our fast-growing business: to highlight our professional capacity and identity as a “medical” AI company and accelerate overseas partnerships and expansion. Brandon’s background as a medical doctor and his proven track record in both medical expertise and business management will help us take our presence and influence in the global medical AI sector into the next level.

Brandon joined Lunit in 2016 and had been working since as our Chief Medical Officer. Our previous CEO and co-founder, Anthony Paek will remain with us as Executive Chairman.

Brandon Suh, M.D. MPH MBA

Brandon studied medicine at Seoul National University College of Medicine and is a board certified physician in Family Medicine, trained at Seoul National University Hospital. Prior to medical school, he graduated from KAIST with a bachelor’s degree in Biological Sciences. He has also received master’s degrees in both Public Health (MPH) and Business Administration (MBA). Brandon has a deep passion for medical research with much experience in both basic and clinical research, having published many articles in world-renowned journals like Hepatology and Annals of Oncology.

Contact us
Jussarang Lee Communications Manager
Jussarang Lee Communications Manager
About Lunit

Perfecting Intelligence. Transforming Medicine.

Lunit, abbreviated from “learning unit,” is a medical AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. It has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit
6th floor, 175 Yeoksam-ro, Gangnam-gu,
Seoul, South Korea

서울시 강남구 역삼로 175 6층 (역삼동, 현승빌딩)